Lumos Pharma Alternatives & Competitors
12 companies similar to Lumos Pharma — Transforming Lives with Rare Focus
Companies similar to Lumos Pharma
Ultragenyx
Going Beyond Every Day
Novato, United States
Pharvaris
Pioneering science for patient choice
Zug, Switzerland
NorthSea Therapeutics
Clinical-stage biopharmaceutical company focused on the development of structurally engine...
Amsterdam, The Netherland...
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
Cambridge, United States
Track all Lumos Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
AIRNA
The next generation of RNA editing therapeutics
Cambridge, United States
Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis a...
Oslo, Norway
Antios Therapeutics
Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...
Atlanta, United States
-Ltd.-logo. "CV6 Therapeutics, (NI) Ltd."){kind=logo}
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
United Kingdom
KeifeRx
KeifeRx is a biopharmaceutical company finding disease-modifying treatments for neurodegen...
Mclean, United States
Forma Therapeutics
Dedicated to transforming the lives of patients with rare hematologic diseases and cancers...
Watertown, United States
Newron Pharmaceuticals SpA
The Specialist in CNS Drug Development
Bresso, Italy
About Lumos Pharma
Lumos Pharma, founded in 1999, is a clinical-stage biopharmaceutical company headquartered in the United States. Known for their slogan, "Transforming Lives with Rare Focus", the company is dedicated to developing new therapies for rare diseases, with a primary emphasis on high-need areas where there is clear pathophys...
Development of therapeutics for rare diseases, Clinical trials for growth deficiencies, Patient advocacy and compassionate use
Patients with rare diseases, Families dealing with growth deficiencies, Healthcare providers, Biopharmaceutical partners
Biopharmaceutical, Clinical-stage, Rare Diseases, Therapeutics, Pediatric Growth Hormone Deficiency, Oral Growth Hormone Therapy, LUM-201, Drug Development, Strategic Partnerships, Therapeutic Candidates, Portfolio Expansion, In-licensing, Creatine Transporter Deficiency, Technology Commercialization, Novel Treatment
B2B, B2C, B2D
Product Sales, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Lumos Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Lumos Pharma on 11 Mar 2026. The 12 companies listed here were last checked between 14 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
